MDXL — Medixall Balance Sheet
0.000.00%
- $0.02m
- $0.58m
- $0.31m
Annual balance sheet for Medixall, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.446 | 0.646 | 0.063 | 0.003 | 0.011 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | — | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.446 | 1.13 | 0.343 | 0.011 | 0.014 |
| Net Property, Plant And Equipment | 0.135 | 0.07 | 0.337 | 0.282 | 0.013 |
| Net Intangible Assets | |||||
| Total Assets | 0.938 | 1.64 | 1.13 | 0.862 | 0.201 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.494 | 1.12 | 1.23 | 4.34 | 6.72 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.54 | 1.26 | 1.47 | 4.53 | 6.72 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.398 | 0.382 | -0.34 | -3.67 | -6.52 |
| Total Liabilities & Shareholders' Equity | 0.938 | 1.64 | 1.13 | 0.862 | 0.201 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |